Loading news article.

Newsfiscal.ai

Cumberland Pharmaceuticals Announces Top-Line Results from Phase 2a ASSIST-SSc Trial

Oct 24, 2026, 09:04 ET · Published

Article summary

Cumberland Pharmaceuticals reported top-line results from its Phase 2a ASSIST-SSc clinical trial evaluating the safety and tolerability of oral ifetroban in patients with systemic sclerosis.

An excerpt from the original article.

Related companies

Cumberland Pharmaceuticals Inc. Common StockCPIXView stock

Analyzed by WAPE AI.

Preparing English content…

Repost

Comments —

Loading comments…